The Efficacy and Cognitive Impact of Perampanel Monotherapy in Patients with Self-Limited Epilepsy with Centrotemporal Spikes: A Retrospective Analysis

OBJECTIVE: The third generation of antiepileptic medication (ASM) perampanel (PER), is mostly used as an add-on treatment for refractory epilepsy patients, and rarely used as a monotherapy. This study aims to observe the efficacy and assess the cognitive effects of PER monotherapy in patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Xuan, Liu, Xiao-Ming, Chen, Jiao, Chen, Hai-Yun, Tan, Qian-Qian, Zhou, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237329/
https://www.ncbi.nlm.nih.gov/pubmed/37274142
http://dx.doi.org/10.2147/NDT.S410858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237329/
https://www.ncbi.nlm.nih.gov/pubmed/37274142
http://dx.doi.org/10.2147/NDT.S410858

Ejemplares similares